GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lumito AB (NGM:LUMITO) » Definitions » Loans Receivable

Lumito AB (NGM:LUMITO) Loans Receivable : kr0.00 Mil (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Lumito AB Loans Receivable?

Lumito AB's Loans Receivable for the quarter that ended in Dec. 2024 was kr0.00 Mil.


Lumito AB Loans Receivable Historical Data

The historical data trend for Lumito AB's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumito AB Loans Receivable Chart

Lumito AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Loans Receivable
Get a 7-Day Free Trial - - - - -

Lumito AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Lumito AB Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Lumito AB Loans Receivable Related Terms

Thank you for viewing the detailed overview of Lumito AB's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Lumito AB Business Description

Traded in Other Exchanges
N/A
Address
Magistratsvagen 10, Lund, SWE, SE-226 43
Lumito AB is a Swedish company that specializes in the medical research and development of imaging technology for use in digital pathology. It has developed a development and business plan for the development of an instrument for digital pathology that improves the quality of tissue sample mapping.

Lumito AB Headlines

No Headlines